ITC of the United States terminated all investigations on Yongan pharmaceutical's taurine products 337

Just now, Yong'an pharmaceutical released the final ruling announcement on the termination of 337 investigation of taurine products by ITC of the United States, saying that by now, all 337 investigation matters related to taurine products of the company have been terminated Up to now, the company's taurine products export and sales activities in the United States are normal Qianjiang Yong'an Pharmaceutical Co., Ltd (hereinafter referred to as "the company") issued the announcement and supplementary announcement on the application of vitaworksip and vitaworks to ITC of the United States for 337 investigation on taurine products of the company on February 12, 2019 According to Section 337 of tariff act of 1930, vitaworksip and vitaworks of the United States applied to ITC of the United States for 337 investigation on taurine products of the company The United States International Trade Commission (hereinafter referred to as "ITC") filed an application against the taurine (2-aminoethanesulfonic acid) products and their production processes for making the same exported, imported or sold in the United States, And products containing the same) infringed its patent right and requested ITC of the United States to launch a 337 investigation and issue a limited exclusion and prohibition order On April 2, 2019, the company issued the notice on the progress of 337 investigation on taurine products filed by ITC in the United States The company learned that the applicants such as vitaworks IP company and vitaworks company proposed a motion to ITC in the United States to suspend the investigation procedure and request to terminate the investigation with the reason of withdrawing the lawsuit The ITC judge of the United States made a decision to suspend the proceedings because the other party submitted a motion to terminate the investigation on the grounds of withdrawal On April 13, 2019, the company issued the announcement on the termination of 337 investigation on taurine products by ITC of the United States, which made a preliminary ruling and approved the motion to terminate the 337 investigation Recently, the company received documents related to the final ruling results of ITC in the United States The US ITC ruled that the 337 investigation will be terminated without reviewing the preliminary ruling of the judge on April 10, 2019 So far, 337 investigation matters related to taurine products of the company have all been ended Up to now, the company's taurine products export and sales activities in the United States are normal.